BMRN - BioMarin gains amid report activist Elliott targeting the drugmaker
2023-11-07 09:00:56 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript
- BioMarin Pharmaceutical says CEO Bienaimé to retire, Hardy to take up post
- BioMarin appoints Alexander Hardy as president and chief executive officer
For further details see:
BioMarin gains amid report activist Elliott targeting the drugmaker